BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20060303)

  • 1. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
    Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
    Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
    Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
    Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
    Krátký M; Janďourek O; Baranyai Z; Novotná E; Stolaříková J; Bősze S; Vinšová J
    Eur J Med Chem; 2019 Nov; 181():111578. PubMed ID: 31401536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains.
    Imramovský A; Vinsová J; Férriz JM; Dolezal R; Jampílek J; Kaustová J; Kunc F
    Bioorg Med Chem; 2009 May; 17(10):3572-9. PubMed ID: 19403314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
    Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
    Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oriented development of antituberculotics: salicylanilides.
    Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
    Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates.
    Baranyai Z; Krátký M; Vosátka R; Szabó E; Senoner Z; Dávid S; Stolaříková J; Vinšová J; Bősze S
    Eur J Med Chem; 2017 Jun; 133():152-173. PubMed ID: 28384546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase.
    Krátký M; Vinšová J; Novotná E; Mandíková J; Wsól V; Trejtnar F; Ulmann V; Stolaříková J; Fernandes S; Bhat S; Liu JO
    Tuberculosis (Edinb); 2012 Sep; 92(5):434-9. PubMed ID: 22765970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
    Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
    Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.
    Krátký M; Vinšová J; Novotná E; Stolaříková J
    Eur J Pharm Sci; 2014 Mar; 53():1-9. PubMed ID: 24333643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
    Krátký M; Volková M; Novotná E; Trejtnar F; Stolaříková J; Vinšová J
    Bioorg Med Chem; 2014 Aug; 22(15):4073-82. PubMed ID: 24953953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-benzylsalicylthioamides: highly active potential antituberculotics.
    Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
    Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
    Vinšová J; Kozic J; Krátký M; Stolaříková J; Mandíková J; Trejtnar F; Buchta V
    Bioorg Med Chem; 2014 Jan; 22(2):728-37. PubMed ID: 24369840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.
    De Logu A; Palchykovska LH; Kostina VH; Sanna A; Meleddu R; Chisu L; Alexeeva IV; Shved AD
    Int J Antimicrob Agents; 2009 Mar; 33(3):223-9. PubMed ID: 19070992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
    de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
    Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A; Soltani F; Moshafi MH
    Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains.
    Krátký M; Vinšová J; Stolaříková J
    Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
    Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
    Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.